Health
New targets for the development of a drug treatment for obesity and type 2 diabetes – Medical Xpress
The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake. This is shown by a recent study by Helmholtz…
The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake. This is shown by a recent study by Helmholtz Zentrum München, ETH Zurich and the German Center for Diabetes Research (DZD). The study, which has now been published in Cell Metabolism, identifies new targets for the development of a drug treatment for obesity and type 2 diabetes.
Dual-agonists targeting the receptors for Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic…
-
General23 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
General23 hours agoAsia stocks plunge, HK suffers steepest fall since 1997
-
Noosa News24 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
Noosa News16 hours agoYoung voices shape Sunshine Coast’s future